RxDoctor Payments Data

Susan Kim, MD

Dermatology · Kirkland, WANPI 1982634507

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,890 of the $12,611 with a category attached, or 62.6%. 22 manufacturers reported payments, led by AbbVie at 35.9% of the total. Among dermatology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,611in general payments, 2019–2025

Across 251 payments — averaging $50.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • Dermavant Sciences, Inc.$3K
  • Sanofi$636
  • E.r. Squibb & Sons, L.L.C.$587
  • Sun Pharmaceutical Industries Inc.$562
  • Arcutis Biotherapeutics, Inc.$508
  • plus $3K from 16 others

What the payments were for

  • Consulting fees$2,00016%
  • Speaking & faculty fees$2,48120%
  • Grants$100%
  • Travel & lodging$190%
  • Food & beverage$7,89063%
  • Education$2122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,611 in reported general payments places this provider in the 90th percentile of 323 dermatology providers in Washington.

See all dermatology providers in Washington

Medicare billing

Part B allowed, 2024
$321,841
Medicare patients
558
Services billed
3,643

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira PenAdalimumab12$85,314
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc88$4,174
Fluorouracil42$3,392
Ketoconazole212$3,316
Clobetasol Propionate85$3,280
Econazole Nitrate60$1,622
ValacyclovirValacyclovir Hcl102$1,406
Desonide36$1,344
Alclometasone Dipropionate40$1,337
Tacrolimus12$1,061
Triamcinolone Acetonide94$837
Cephalexin55$550
Fluocinonide12$505
Metronidazole16$480
Doxycycline Monohydrate21$440

Paid to pharmacies, not to this prescriber.

Other dermatology in Kirkland

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →